Stemtech (STEK) Amortizatization of Intangibles (2012 - 2025)
Stemtech's (STEK) quarterly Amortizatization of Intangibles came in at $8788.0 in Q4 2025, up 105.04% year-on-year from $4285.9 in Q4 2024, and down 74.75% quarter-over-quarter from $34806.0 in Q3 2025.
Stemtech (STEK) Amortizatization of Intangibles (2012 - 2025) Analysis & Trends
Stemtech has disclosed Amortizatization of Intangibles across 11 years of filings, most recently posting $8788.0 for Q4 2025.
- Amortizatization of Intangibles for Q4 2025 came in at $8788.0, up 105.04% year-over-year; the trailing twelve-month figure through Sep 2025 was -$183060.0 (up 90.02% YoY), and the FY2024 annual result was $362404.0, up 403.47% from the prior year.
- Amortizatization of Intangibles came in at $8788.0 for Q4 2025 at Stemtech, down from $34806.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.4 million in Q3 2023 to a low of -$2.4 million in Q4 2022.
- The 5-year median for Amortizatization of Intangibles is $11893.0 (2021), against an average of $54588.0.
- Peak annual rise in Amortizatization of Intangibles reached 16103.13% in 2023, while the deepest fall reached 4138.35% in 2023.
- Stemtech's Amortizatization of Intangibles stood at $463890.0 in 2021, then plunged by 617.51% to -$2.4 million in 2022, then increased by 1.21% to -$2.4 million in 2023, then jumped by 92.65% to -$174272.0 in 2024, then jumped by 105.04% to $8788.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $8788.0 (Q4 2025), $34806.0 (Q3 2025), and -$43594.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Stemtech | - | - | 354,677.00 | 8,788.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,788.00 |
| Dec 31, 2025 | 8,788.00 |
| Sep 30, 2025 | 34,806.00 |
| Sep 30, 2025 | 34,806.00 |
| Jun 30, 2025 | -43,594.00 |
| Jun 30, 2025 | -43,594.00 |
| Dec 31, 2024 | -174,272.00 |
| Dec 31, 2024 | -174,272.00 |
| Sep 30, 2024 | 491,261.00 |
| Sep 30, 2024 | 491,261.00 |
| Jun 30, 2024 | -396,173.00 |
| Jun 30, 2024 | -396,173.00 |
| Mar 31, 2024 | 441,588.00 |
| Mar 31, 2024 | 441,588.00 |
| Dec 31, 2023 | -2.37 Mn |
| Dec 31, 2023 | -2.37 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | -1.48 Mn |
| Jun 30, 2023 | -1.48 Mn |